程序性细胞死亡
体内
车站3
癌症研究
细胞凋亡
活力测定
溶酶体
细胞生长
生物
药理学
化学
生物化学
生物技术
酶
作者
Marvin Xuejun Xu,Xinxin Liu,Hai‐Liang Zhang,Hongyun Xu,Xiangyu Ma,Yupo Yang,Chaoqun Duan,Shuai Tang,Yaqing Liu,Cen Li,Maohua Pei,Jing Xia,Yali Yang,Yanmin Guo,Yang Wang,Songping Luo,Jianguo Ma,Zhengyan Yang,Xiao‐Feng Zhu,Chunping Xu
摘要
RDp002 is a novel STAT3 inhibitor that exerts potent anti-tumour effects mainly by inducing lysosome-dependent cell death. RDp002 represents a promising therapeutic lead for TNBC and MM.
科研通智能强力驱动
Strongly Powered by AbleSci AI